These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 1777161)

  • 1. Beta 2-microglobulin levels in drug users: the influence of risk behaviour.
    Flegg PJ; Brettle RP; Robertson JR; Clarkson RC; Bird AG
    AIDS; 1991 Aug; 5(8):1021-4. PubMed ID: 1777161
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunologic marker paths for seroconversion: single determinations of immunoglobulin A and beta 2-microglobulin are not adequate to estimate time of HIV infection. Multicohort Analysis Project Workshop. Part II.
    AIDS; 1994 Jul; 8(7):923-33. PubMed ID: 7946101
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunologic markers of AIDS progression: consistency across five HIV-infected cohorts. Multicohort Analysis Project Workshop. Part I.
    AIDS; 1994 Jul; 8(7):911-21. PubMed ID: 7946100
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum B2-microglobulin and human immunodeficiency virus infection in intravenous drug users: a cross-sectional study.
    De Mercato R; Rezza G; Giuliani M; Perna E; Iovinella V; Bassi A; Tagliaferro R
    Boll Ist Sieroter Milan; 1990 Jun; 69(2):447-8. PubMed ID: 2152304
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of beta 2-microglobulin level and CD4 lymphocyte count to predict development of acquired immunodeficiency syndrome in persons with human immunodeficiency virus infection.
    Anderson RE; Lang W; Shiboski S; Royce R; Jewell N; Winkelstein W
    Arch Intern Med; 1990 Jan; 150(1):73-7. PubMed ID: 1967523
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preference for sex on amphetamine: a marker for HIV risk behaviour among male intravenous amphetamine users in Stockholm.
    Käll K; Nilsonne A
    AIDS Care; 1995; 7(2):171-88. PubMed ID: 7619871
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Little HIV risk behavior in drug users during detention in Dutch penitentiaries].
    van Haastrecht HJ; Bax JS; van den Hoek JA
    Ned Tijdschr Geneeskd; 1997 Mar; 141(9):429-33. PubMed ID: 9173303
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum beta 2-microglobulin level increases in HIV infection: relation to seroconversion, CD4 T-cell fall and prognosis.
    Hofmann B; Wang YX; Cumberland WG; Detels R; Bozorgmehri M; Fahey JL
    AIDS; 1990 Mar; 4(3):207-14. PubMed ID: 1972020
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changes in markers of disease progression in HIV-1 seroconverters: a comparison between cohorts of injecting drug users and homosexual men.
    Galai N; Vlahov D; Margolick JB; Chen K; Graham NM; Muñoz A
    J Acquir Immune Defic Syndr Hum Retrovirol; 1995 Jan; 8(1):66-74. PubMed ID: 8548349
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Seroprevalence of and risk factors for HIV-1 infection in injection drug users in Montreal and Toronto: a collaborative study.
    Lamothe F; Bruneau J; Coates R; Rankin JG; Soto J; Arshinoff R; Brabant M; Vincelette J; Fauvel M
    CMAJ; 1993 Oct; 149(7):945-51. PubMed ID: 8402423
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of HCV and HBV markers in Spanish HIV-seropositive patients in relation to risk practices.
    Rodríguez-Méndez ML; González-Quintela A; Aguilera A; Carballo E; Barrio E
    Hepatogastroenterology; 2003; 50(54):2093-7. PubMed ID: 14696471
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Beta 2-microglobulin, HIV-1 p24 antibody and acid-dissociated HIV-1 p24 antigen levels: predictive markers for vertical transmission of HIV-1 in pregnant Ugandan women.
    Jackson JB; Kataaha P; Hom DL; Mmiro F; Guay L; Ndugwa C; Marum L; Piwowar E; Brewer K; Toedter G
    AIDS; 1993 Nov; 7(11):1475-9. PubMed ID: 8280414
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Direct comparison of the relationship between clinical outcome and change in CD4+ lymphocytes in human immunodeficiency virus-positive homosexual men and injecting drug users.
    Margolick JB; Muñoz A; Vlahov D; Astemborski J; Solomon L; He XY; Nelson KE; Saah AJ
    Arch Intern Med; 1994 Apr; 154(8):869-75. PubMed ID: 7908795
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Injection drug use and crack cocaine smoking: independent and dual risk behaviors for HIV infection.
    McCoy CB; Lai S; Metsch LR; Messiah SE; Zhao W
    Ann Epidemiol; 2004 Sep; 14(8):535-42. PubMed ID: 15350952
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elevated serum levels of neopterin but not beta 2-microglobulin in HIV-1-seronegative injecting drug users.
    Strickler HD; Blanchard JF; Vlahov D; Taylor E; Muñoz A; Nelson KE; Margolick JB
    AIDS; 1993 Mar; 7(3):361-7. PubMed ID: 8471199
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunohaematological findings in healthy and HIV-1 infected adults in Dar es Salaam, Tanzania.
    Urassa WK; Lyamuya EF; Mbena E; Kagoma C; Bredberg Raden U; Pallangyo KP; Magessa P; Mhalu FS; Biberfeld G
    East Afr Med J; 1996 Oct; 73(10):670-4. PubMed ID: 8997848
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HIV risk behaviors and HIV seropositivity among young injection drug users.
    Marrero Rodríguez CA; Robles RR; Colón HM; Freeman DH; Matos TD; Reyes JC
    P R Health Sci J; 1993 Apr; 12(1):7-12. PubMed ID: 8511250
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Demographic, HIV risk behavior, and health status characteristics of "crack" cocaine injectors compared to other injection drug users in three New England cities.
    Buchanan D; Tooze JA; Shaw S; Kinzly M; Heimer R; Singer M
    Drug Alcohol Depend; 2006 Feb; 81(3):221-9. PubMed ID: 16171952
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preparations for AIDS vaccine trials. Retention, behavior change, and HIV-seroconversion among injecting drug users (IDUs) and sexual partners of IDUs.
    Marmor M; Titus S; Wolfe H; Krasinski K; Maslansky R; Simberkoff M; Beatrice S; Nichols S; Des Jarlais DC
    AIDS Res Hum Retroviruses; 1994; 10 Suppl 2():S207-13. PubMed ID: 7865302
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Risk reduction and intravenous drug use abstinence in patients with HIV infection. The SEROCO group].
    Meyer L; Wade A; Persoz A; Boué F; Dellamonica P; Caroli-Bosc C; Carré N
    Rev Epidemiol Sante Publique; 1998 Feb; 46(1):34-9. PubMed ID: 9533232
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.